American Board of Optometry wins recent lawsuit

Article

Although the American Board of Optometry (ABO) was declared the winner in the recent American Optometric Society's (AOS) lawsuit against the organization, AOS President Pam Miller, OD, FAAO, JD, doesn't consider it a loss.

Key Points

Although the American Board of Optometry (ABO) was declared the winner in the recent American Optometric Society's (AOS) lawsuit against the organization, AOS President Pam Miller, OD, FAAO, JD, doesn't consider it a loss.

Instead, she said the AOS won significantly by keeping an injunction from 2011 in place-the ABO cannot claim that board-certified optometrists are any more qualified or competent than their colleagues who are licensed but have not sought certification.

Failing to prove that board certification offered a competitive advantage, could potentially cause economic damage and represented value to consumers beyond a medical license, AOS did not receive an injunction prohibiting the ABO from calling its program "board certification."

"To be considered an optometrist, you need to maintain a state license, and by being acknowledged by the American Board of Certification in Medical Optometry (ABCMO) is in effect already being certified," Dr. Miller said.

On the other side, the ABO said the AOS alleged that using "board-certified" was confusing to the public, an issue with which the Court disagreed.

"Board certification can demonstrate that optometrists are enrolled in a lifetime commitment to maintaining competence," Dr. Cockrell said. "The program is voluntary and serves as a measuring stick: 'Am I current?'"

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.